Stephen Dale

Executive Officer at Syncromune.

Earliest Form D on file: May 2026

Filed May 11, 2026Amendment

Syncromune

Cryoablation-based immunotherapy for prostate cancer

Biotech, Fort Lauderdale FL

Named, Executive Officer.

$144.8M

sold of $144.8M offered

Reported on an amendment to an earlier filing.

Network

At Syncromune

9 people

Eamonn Hobbs
Executive Officer, Director, signed as Chief Executive Officer
Charles J. Link
Executive Officer, Director
Agustin Gago
Executive Officer
Douglas G. Watson
Director
JEFFREY CLELAND
Director
Joseph C. Maroon
Director

3 more at Syncromune